Human CCL1/I-309/TCA-3 Antibody, R&D Systems™

CCL1/I-309/TCA-3

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

C-C motif chemokine 1, chemokine (C-C motif) ligand 1, I-309, inflammatory cytokine I-309, P500, SCYA1, SCYA1Small-inducible cytokine A1, SCYA2, SISe, small inducible cytokine A1 (I-309, homologous to mouse Tca-3), T lymphocyte-secreted protein I-309, TCA3, TCA-3

Mouse

Protein A or G purified from ascites

RUO

6346

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot, Neutralization, ELISA

35305

Western Blot 1 ug/mL, Neutralization 0.1-0.5 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

P22362

CCL1

E. coli-derived recombinant human CCL1/I-309/TCA-3 Lys24-Lys96 Accession # P22362

500 μg

Primary

Detects human CCL1/I-309/TCA-3 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant human CCL2, 3, 4, 5, 7, 8, 9/10/MIP-1 gamma , 11, 14, 17, 19, 20, 21, 25, 28, recombinant mouse CCL2, 3, 5, 6, 7, 9/10/MIP-1 gamma , 11, 21, or 25 is observed.

Human

Purified